Court Grants Attorney Withdrawal in Brown v. Mead Johnson Formula Suit

A motion was filed on April 19, 2026 in Brown v. Mead Johnson & Company LLC et al, docket 23-cv-01979. The docket number places the original filing in 2023, but the court and assigned judge remain unconfirmed in available records.

The most recent docket activity is an order on a motion to withdraw as attorney, entry 15. Counsel withdrawal at this stage is worth watching. It can signal a settlement negotiation breakdown, a fee dispute, or a client who has decided to change strategy mid-litigation.

Mead Johnson is the infant formula manufacturer behind the Enfamil brand. Cases filed against Mead Johnson in this period have generally alleged that the company's cow's milk-based formula caused necrotizing enterocolitis (NEC) in premature infants. If Brown follows that pattern, the core claim is that Mead Johnson knew its product carried raised NEC risk for preterm infants and failed to warn hospitals and parents.

NEC litigation against Mead Johnson and Abbott Laboratories has been consolidated in the Northern District of Illinois as a multidistrict litigation (MDL), In re Preterm Infant Nutrition Products Liability Litigation, MDL No. 3026. Whether Brown is part of that MDL or proceeding independently is not confirmed by the available docket data.

That distinction matters: MDL cases move on a coordinated schedule set by the transferee judge, while standalone cases move on their own track.

With no judge assigned and sparse docket detail, this case is either in early stages, stayed pending MDL coordination, or administratively dormant. The attorney withdrawal motion is the only visible sign of life.